TY - JOUR
T1 - Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS
AU - Almad, Akshata A.
AU - Taga, Arens
AU - Joseph, Jessica
AU - Gross, Sarah K.
AU - Welsh, Connor
AU - Patankar, Aneesh
AU - Richard, Jean Philippe
AU - Rust, Khalil
AU - Pokharel, Aayush
AU - Plott, Caroline
AU - Lillo, Mauricio
AU - Dastgheyb, Raha
AU - Eggan, Kevin
AU - Haughey, Norman
AU - Contreras, Jorge E.
AU - Maragakis, Nicholas J.
N1 - Publisher Copyright:
Copyright © 2022 the Author(s).
PY - 2022/3/29
Y1 - 2022/3/29
N2 - Connexin 43 (Cx43) gap junctions and hemichannels mediate astrocyte intercellular communication in the central nervous system under normal conditions and contribute to astrocyte-mediated neurotoxicity in amyotrophic lateral sclerosis (ALS). Here, we show that astrocyte-specific knockout of Cx43 in a mouse model of ALS slows disease progression both spatially and temporally, provides motor neuron (MN) protection, and improves survival. In addition, Cx43 expression is up-regulated in human postmortem tissue and cerebrospinal fluid from ALS patients. Using human induced pluripotent stem cell–derived astrocytes (hiPSC-A) from both familial and sporadic ALS, we establish that Cx43 is up-regulated and that Cx43-hemichannels are enriched at the astrocyte membrane. We also demonstrate that the pharmacological blockade of Cx43-hemichannels in ALS astrocytes using GAP 19, a mimetic peptide blocker, and tonabersat, a clinically tested small molecule, provides neuroprotection of hiPSC-MN and reduces ALS astrocyte-mediated neuronal hyperexcitability. Extending the in vitro application of tonabersat with chronic administration to SOD1G93A mice results in MN protection with a reduction in reactive astrocytosis and microgliosis. Taking these data together, our studies identify Cx43 hemichannels as conduits of astrocyte-mediated disease progression and a pharmacological target for disease-modifying ALS therapies.
AB - Connexin 43 (Cx43) gap junctions and hemichannels mediate astrocyte intercellular communication in the central nervous system under normal conditions and contribute to astrocyte-mediated neurotoxicity in amyotrophic lateral sclerosis (ALS). Here, we show that astrocyte-specific knockout of Cx43 in a mouse model of ALS slows disease progression both spatially and temporally, provides motor neuron (MN) protection, and improves survival. In addition, Cx43 expression is up-regulated in human postmortem tissue and cerebrospinal fluid from ALS patients. Using human induced pluripotent stem cell–derived astrocytes (hiPSC-A) from both familial and sporadic ALS, we establish that Cx43 is up-regulated and that Cx43-hemichannels are enriched at the astrocyte membrane. We also demonstrate that the pharmacological blockade of Cx43-hemichannels in ALS astrocytes using GAP 19, a mimetic peptide blocker, and tonabersat, a clinically tested small molecule, provides neuroprotection of hiPSC-MN and reduces ALS astrocyte-mediated neuronal hyperexcitability. Extending the in vitro application of tonabersat with chronic administration to SOD1G93A mice results in MN protection with a reduction in reactive astrocytosis and microgliosis. Taking these data together, our studies identify Cx43 hemichannels as conduits of astrocyte-mediated disease progression and a pharmacological target for disease-modifying ALS therapies.
KW - astrocyte
KW - connexin
KW - stem cells
UR - http://www.scopus.com/inward/record.url?scp=85126894486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126894486&partnerID=8YFLogxK
U2 - 10.1073/pnas.2107391119
DO - 10.1073/pnas.2107391119
M3 - Article
C2 - 35312356
AN - SCOPUS:85126894486
SN - 0027-8424
VL - 119
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 13
M1 - e2107391119
ER -